Quantitative CT bone mineral densitometry is a method to accurately measure bone density and strength. It is one of the methods cited by the National Osteoporosis Foundation as useful and safe in the evaluation of osteoporosis. The data are used to measure an important fracture risk factor and determine the necessity, choice and efficacy of therapy. The results are reproducible, allowing measurements to be taken over time showing progression of disease or improvement in bone density due to treatment.
Clinical indications for CT bone mineral densitometry defined by the National Osteoporosis Foundation include:
The QCT examination is performed on a modern CT scanner and takes approximately 10 minutes:
In the years following menopause, women will naturally experience bone loss because of a decrease in estrogen. Most will have no symptoms, even while the disease progresses. These factors add to your risk of developing osteoporosis.
Prevention of osteoporosis, delaying its onset or lessening its severity will result in decreasing the chance of osteoporotic fractures, which can lead to pain, lack of mobility and even increase the chance of death. There are now treatments to prevent osteoporosis, once it has been diagnosed.
CT bone densitometry and DEXA both measure spinal bone mass, a significant advantage over other methods, such as ultrasound, which measure bone in the peripheral skeleton where bone density is slow to change in response to disease therapy. Spinal bone is a mixture of trabecular (spongy) bone and slowly-changing cortical (compact) bone. DEXA measures the sum of these two compartments but also includes aortic calcification and osteophytes in the calculation of bone mineral in the spine. Only CT bone mineral densitometry isolates the metabolically-active trabecular bone for analysis. New ultrasound methods for the knee or the heel are being used for osteoporosis screening, but unlike CT or DEXA they do not measure bone mass, and cannot be used to measure the spine where most osteoporotic fractures occur.
All bone density measurements, except ultrasound, use small amounts of radiation to determine the amount of bone present. For a CT bone density study, the exposure is restricted to four 10 mm-thick slices of the abdomen and a lateral digital radiograph. There is no measurable gonadal exposure for the low-dose methods normally used for QCT. The relative radiation exposure to the bone marrow is about the same as 5 mrem to the whole body. For comparison, a chest x-ray would be about 3 mrem whole-body-equivalent, a cross-country plane flight is about 2 mrem, and natural background is about 365 mrem per year.